These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7027518)

  • 1. [Cardiovascular effects of calcium antagonists drug (author's transl)].
    Thuillez C; Giudicelli JF
    Therapie; 1981; 36(2):107-21. PubMed ID: 7027518
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiovascular effects of calcium antagonists].
    Pasanisi F; Marino A
    Clin Ter; 1989 Jul; 130(1):3-10. PubMed ID: 2529078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium antagonism: aldosterone and vascular responses to catecholamines and angiotensin II in man.
    Elliott HL
    J Hypertens Suppl; 1993 Dec; 11(6):S13-6. PubMed ID: 8169376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calcium antagonists and calmodulin].
    Blahos J
    Cas Lek Cesk; 1984 Mar; 123(11):305-11. PubMed ID: 6705021
    [No Abstract]   [Full Text] [Related]  

  • 5. Calcium channel antagonists: cardiovascular selectivity of action.
    Sun J; Triggle DJ
    J Pharmacol Exp Ther; 1995 Jul; 274(1):419-26. PubMed ID: 7616426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of tetramethylpyrazine on the cardiovascular system].
    Wang ZL
    Sheng Li Ke Xue Jin Zhan; 1992 Oct; 23(4):313-7. PubMed ID: 1338806
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of some calcium antagonists in an experimental model of cardio-cerebral relationships].
    Di Giugno G; Mattioli GL; Rosa G; Ferrante L; Alampi D; Caruso R; Cantore GP
    Minerva Anestesiol; 1993 Oct; 59(10 Suppl 3):47-57. PubMed ID: 8290108
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular system drugs. 2/12. Calcium inhibitors].
    Fein E; Limat S
    Soins; 2004 Apr; (684 Pt 1):61-2. PubMed ID: 15151081
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiovascular protection by estrogens: a calcium antagonist effect?].
    Sánchez García P
    An R Acad Nac Med (Madr); 1994; 111(4):779-82. PubMed ID: 7598211
    [No Abstract]   [Full Text] [Related]  

  • 11. CV response to calcium-entry blocking drugs.
    Millard RW; Schwartz A
    Circulation; 1982 Oct; 66(4):902. PubMed ID: 7116608
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcium channel blockers in shock.
    Hess ML; Mahany TM; Greenfield LJ
    Prog Clin Biol Res; 1983; 111():271-82. PubMed ID: 6346331
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppressive properties of calcium channel blockers.
    Chitwood KK; Heim-Duthoy KL
    Pharmacotherapy; 1993; 13(5):447-54. PubMed ID: 8247910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute loading with catecholamines on young pigs in combined inhalation anaesthesia after simultaneous premedication with atropine and azaperone (author's transl)].
    Buntenkötter S
    Dtsch Tierarztl Wochenschr; 1981 Jun; 88(6):222-5. PubMed ID: 7026209
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of dietary salts on the cardiovascular effects of low-dose combination of ramipril and felodipine in spontaneously hypertensive rats.
    Mervaala EM; Malmberg L; Teräväinen TL; Laakso J; Vapaatalo H; Karppanen H
    Br J Pharmacol; 1998 Jan; 123(2):195-204. PubMed ID: 9489606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium antagonists. Great tissue selectivity is the basis of their therapeutic use].
    Högestätt ED; Andersson KE
    Lakartidningen; 1997 Sep; 94(36):3024-6, 3029-31. PubMed ID: 9312623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels.
    Yang ZQ; Barrow JC; Shipe WD; Schlegel KA; Shu Y; Yang FV; Lindsley CW; Rittle KE; Bock MG; Hartman GD; Uebele VN; Nuss CE; Fox SV; Kraus RL; Doran SM; Connolly TM; Tang C; Ballard JE; Kuo Y; Adarayan ED; Prueksaritanont T; Zrada MM; Marino MJ; Graufelds VK; DiLella AG; Reynolds IJ; Vargas HM; Bunting PB; Woltmann RF; Magee MM; Koblan KS; Renger JJ
    J Med Chem; 2008 Oct; 51(20):6471-7. PubMed ID: 18817368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular T-type calcium channels: physiological and pharmacological significance.
    Triggle DJ
    J Hypertens Suppl; 1997 Dec; 15(5):S9-15. PubMed ID: 9481611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium antagonists--a new class of drugs used in the treatment of lung diseases (current status and outlook)].
    Mihălţan F
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1986; 35(4):289-97. PubMed ID: 3031799
    [No Abstract]   [Full Text] [Related]  

  • 20. [The cardiovascular effects of serotonin receptor agonists and antagonists (I)].
    Villalón CM; Terrón JA; Hong E; Saxena PR
    Arch Inst Cardiol Mex; 1993; 63(5):441-7. PubMed ID: 8291931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.